Development of a risk-priority score for category a bioterrorism agents as an aid for public health policy

被引:22
作者
MacIntyre, C. Raina [1 ]
Seccull, Alison
Lane, J. Michael
Plant, Aileen
机构
[1] Childrens Hosp, Natl Ctr Immunisat Res & Surveillance Vaccine Pre, Westmead, NSW, Australia
[2] Univ Sydney, Sydney, NSW 2006, Australia
[3] Dept Human Serv, Victorian Publ Hlth Training Scheme, Melbourne, Vic, Australia
[4] Ctr Dis Control, Smallpox Eradicat Program, Atlanta, GA 30333 USA
[5] Curtin Univ Technol, Bentley, WA 6102, Australia
关键词
D O I
10.7205/MILMED.171.7.589
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
In developing public health policy and planning for a bioterrorist attack or vaccination of military personnel, the most common method for assigning priority is using the probability of attack with a particular agent as the single criterion. Using this approach, smallpox is often dismissed as an unlikely threat. We aimed to develop an evidence-based, systematic, multifactorial method for prioritizing the level of risk of each category A bioterrorism agent. Using 10 criterion, anthrax scored the highest, followed by smallpox. Tularemia was the lowest scoring agent. We suggest that such a system would be useful for developing public policy, stockpiling of vaccines and therapeutics, vaccination of military personnel, and planning for public health responses to a bioterrorist attack.
引用
收藏
页码:589 / 594
页数:6
相关论文
共 39 条
  • [21] Anthrax as a biological weapon, 2002 - Updated recommendations for management
    Inglesby, TV
    O'Toole, T
    Henderson, DA
    Bartlett, JG
    Ascher, MS
    Eitzen, E
    Friedlander, AM
    Gerberding, J
    Hauer, J
    Hughes, J
    McDade, J
    Osterholm, MT
    Parker, G
    Perl, TM
    Russell, PK
    Tonat, K
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2002, 287 (17): : 2236 - 2252
  • [22] Plague as a biological weapon - Medical and public health management
    Inglesby, TV
    Dennis, DT
    Henderson, DA
    Bartlett, JG
    Ascher, MS
    Eitzen, E
    Fine, AD
    Friedlander, AM
    Hauer, J
    Koerner, JF
    Layton, M
    McDade, J
    Osterholm, MT
    O'Toole, T
    Parker, G
    Perl, TM
    Russell, PK
    Schoch-Spana, M
    Tonat, K
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2000, 283 (17): : 2281 - 2290
  • [23] Anthrax as a biological weapon - Medical and public health management
    Inglesby, TV
    Henderson, DA
    Bartlett, JG
    Ascher, MS
    Eitzen, E
    Friedlander, AM
    Hauer, J
    McDade, J
    Osterholm, MT
    O'Toole, T
    Parker, G
    Perl, TM
    Russell, PK
    Tonat, K
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1999, 281 (18): : 1735 - 1745
  • [24] JEFFERSON T, 2000, COCHRANE DB SYST REV
  • [25] Biological weapons control - Prospects and implications for the future
    Kadlec, RP
    Zelicoff, AP
    Vrtis, AM
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1997, 278 (05): : 351 - 356
  • [26] Allelic exchange in Francisella tularensis using PCR products
    Lauriano, CM
    Barker, JR
    Nano, FE
    Arulanandarn, BP
    Klose, KE
    [J]. FEMS MICROBIOLOGY LETTERS, 2003, 229 (02) : 195 - 202
  • [27] Modelling responses to a smallpox epidemic taking into account uncertainty
    Legrand, J
    Viboud, C
    Boelle, PY
    Valleron, AJ
    Flahault, A
    [J]. EPIDEMIOLOGY AND INFECTION, 2004, 132 (01) : 19 - 25
  • [28] Malloy C D, 2000, J Public Health Manag Pract, V6, P30
  • [29] Modeling potential responses to smallpox as a bioterrorist weapon
    Meltzer, MI
    Damon, I
    LeDuc, JW
    Millar, JD
    [J]. EMERGING INFECTIOUS DISEASES, 2001, 7 (06) : 959 - 969
  • [30] THE SVERDLOVSK ANTHRAX OUTBREAK OF 1979
    MESELSON, M
    GUILLEMIN, J
    HUGHJONES, M
    LANGMUIR, A
    POPOVA, I
    SHELOKOV, A
    YAMPOLSKAYA, O
    [J]. SCIENCE, 1994, 266 (5188) : 1202 - 1208